Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma

Fig. 6

PCA and functional enrichment analysis. (A-D). The 3D PCA showing the distribution differences between the high- and low-risk groups according to the entire gene expression (A), DRGs (B), DRLs (C), and the risk model genes (D). (E). GO functional enrichment analysis with a histogram plot (BP, biological process; CC, cellular component; MF, molecular function). (F) KEGG pathway enrichment analysis with a histogram plot

Back to article page